$1.11
-0.17-13.62%
Last update: Nov 9, 7:18 PM
ALX Oncology Holdings Inc
ALXONASDAQ
The average analyst price target for ALX Oncology Holdings is $3.93, 227.5% above the current price. Of 7 analysts, 6 rate it Buy and 1 Hold. Targets range from $1 to $9. The latest change came on Mar 19, 2026, when Wells Fargo initiated coverage of ALX Oncology Holdings with an Overweight rating and a $5 price target.
Price Target Range — 8 Quarters
Analyst Consensus — 7 Analysts
Rating Trend — Last 9 Months
